http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment
-
Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' Klotho
-
Avant Technologies shifts to biotech partnerships model
-
Avant Technologies, Inc. Bolsters Strategic Vision with Targeted Biotech Partnerships for Innovative Cell-Based Therapies
-
Avant Technologies forms diabetes treatment joint venture
-
Avant Technologies, Art-Islets, and Austrianova Announce Joint Venture to Advance Diabetes Treatment
-
Avant Technologies forms joint venture with Austrianova for klotho therapies
-
Avant Technologies and Austrianova Sign Joint Venture, Licensing Agreement to Advance Klotho-Based Therapies
-
Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
-
Avant Technologies revises clinical trial protocol after FDA meeting
-
Avant Technologies and Ainnova Tech Advance Clinical Trial Protocol Following FDA Feedback
-
Avant Technologies' Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference
-
Avant Technologies and Ainnova meet with FDA on AI diabetic screening trial
-
Avant Technologies and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA
-
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America
-
Avant Technologies (AVAI) and JV Partner, Ainnova, Prepare for Key FDA Milestone with Next Week's Pre-Submission Meeting
-
Avant Technologies and JV Partner, Ainnova, Prepare for Key FDA Milestone with Next Week's Pre-Submission Meeting
-
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies
-
Avant Technologies and Partner, Ainnova, Finalizing Automated Retinal Camera Prototype Ahead of Full-Scale Development
-
Avant Technologies Signs Letter of Intent for a Business Combination
-
Avant Technologies and Partner, Ainnova, Finalizing Automated Retinal Camera Prototype Ahead of Full-Scale Development
-
Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform
-
Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform
-
Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting
-
Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting
-
Avant Technologies and Ainnova Tech Begin Acquisition Talks Ahead of FDA Pre-Submission Meeting
-
Avant Technologies and Ainnova Tech Begin Acquisition Talks Ahead of FDA Pre-Submission Meeting
-
Avant Technologies and Partner, Ainnova, Receive FDA Pre-Submission Meeting Date for Company’s Vision AI Platform Technology
-
Avant Technologies and Partner, Ainnova, Receive FDA Pre-Submission Meeting Date for Company's Vision AI Platform Technology
-
Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology
-
Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology
-
Avant Technologies and JV Partner, Ainnova, Accelerate Expansion Across Latin America Following Key Role at Healthcare Innovation Summit
-
Avant Technologies and JV Partner, Ainnova, Accelerate Expansion Across Latin America Following Key Role at Healthcare Innovation Summit
-
Avant Technologies Partner, Ainnova, to Sponsor and Present at 2025 Healthcare Innovation Summit in Mexico City
-
Avant Technologies Partner, Ainnova, to Sponsor and Present at 2025 Healthcare Innovation Summit in Mexico City
-
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform
-
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform
-
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare
-
Avant Technologies Reaches Global Development and Licensing Deal with Partner, Ainnova Tech, Ahead of FDA Meetings
-
Avant Technologies JV Partner to Speak at AI Revolution in Healthcare Summit in Dubai
-
Avant Technologies and Ainnova Advance Toward FDA Clinical Trial with Selection of Top CRO
-
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform
-
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases
-
Game Changing AI Applications from Healthcare to Marketing to Gaming
-
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care
-
Avant Technologies (AVAI) Announces Strategic Review Process Intended to Maximize Shareholder Value
-
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value
-
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions
-
Avant Technologies Unveils AI-Powered Healthcare Infrastructure to Deliver Intelligent Healthcare Solutions
-
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies
